SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-102352
Filing Date
2022-09-22
Accepted
2022-09-22 16:30:48
Documents
2
Period of Report
2022-09-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2226421-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2226421-1_3seq1.xml 3 1618
2 LIMITED POWER OF ATTORNEY tm2226421d1_ex24-1.htm EX-24.1 10212
  Complete submission text file 0001104659-22-102352.txt   13374
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KIORA PHARMACEUTICALS, INC. 1371 EAST 2100 SOUTH, SUITE 200 SALT LAKE CITY UT 84105
Business Address
Tosca Melissa (Reporting) CIK: 0001947184 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 221259518